Model Number 3CX*FX25REC |
Device Problem
Contamination (1120)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 07/15/2021 |
Event Type
malfunction
|
Manufacturer Narrative
|
Terumo has not received the device for evaluation; therefore, the investigation has yet to be completed.Terumo plans on submitting a follow-up report when the investigation is complete and when more information becomes available.(b)(4).
|
|
Event Description
|
The user facility reported to terumo cardiovascular that prior to cardiopulmonary bypass, during non clinical activity, there was black spot in the material noted.No patient involvement.
|
|
Manufacturer Narrative
|
This follow-up report is submitted, to fda in accord with applicable regulations.And as indicated, by terumo cardiovascular systems in the initial report submitted to the fda on august 4, 2021 upon further investigation of the reported event.The following information is new and/or changed: d9: (device availability, added date returned to manufacturer).G3: (date received by manufacturer).G6: (indication that this is a follow-up report).H2: (follow-up, due to additional information).H3: (device evaluation anticipated by manufacturer, a second follow-up will be submitted, upon completion of the investigation and/or submission of new information.Thus, tcvs references conclusions code 11).All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|
|
Manufacturer Narrative
|
This follow-up report is submitted, to fda in accord with applicable regulations.Upon further investigation of the reported event.The following information is new and/or changed: d4: (additional device information, added expiration date).G3: (date received by manufacturer).G6: (indication that this is a follow-up report).H2: (follow-up, due to additional information and device evaluation).H3: (device evaluated by manufacturer).H4: (device manufacture date).H6: (identification of evaluation codes 10, 11, 3331, 3259, 4307).Type of investigation: #1: 10, testing of actual/suspected device.Type of investigation #2: 11, testing of device from same lot/batch retained by manufacturer.Type of investigation #3: 3331, analysis of production records.Investigation findings: 3259, improper physical structure.Investigation conclusions: 4307, cause traced to component failure.The affected sample was inspected upon receipt to confirm, a mark in the reservoir.Further inspection revealed, that the marking is embedded within the plastic.A representative retention sample was inspected to show, no anomalies with the device, including no foreign matter.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|
|
Search Alerts/Recalls
|
|